Clinically, MCP-1 levels in the serum and cerebrospinal fluid (CSF) are elevated in patients with mild cognitive impairment (MCI) and mild AD5,6, and there is a significant relationship between CSF and plasma levels of MCP-17. The gene discussed is CCL2; the disease is Cognitive impairment.